Pancreatic Cancer Research

ResearcherThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteActive in the last 2 years

Ahmad Hegazi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1985-2214; OpenAlex author ID A5059174975. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Advancing Immunotherapy in Pancreatic Cancer. Co-author DOI 10.3390/ijms252111560↗
  2. Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic… Co-author DOI 10.1158/1078-0432.ccr-20-1422↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kuo‐Hui Su · 1 shared paper, 2024 · strength 0.31
  2. Adam R. Wolfe · 1 shared paper, 2021 · strength 0.12
  3. Zobeida Cruz‐Monserrate · 1 shared paper, 2021 · strength 0.12
  4. Ryan N. Robb · 1 shared paper, 2021 · strength 0.12
  5. Terence Marques Williams · 1 shared paper, 2021 · strength 0.12
  6. Jose Gilberto Trevino · 1 shared paper, 2021 · strength 0.12
  7. Laith I. Abushahin · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.